Circulating Interleukin-22 Is a Biomarker for Newly Diagnosed Type 2 Diabetes Mellitus and Associated with Hypoglycemic Effect of Sitagliptin

Circulating Interleukin-22 Is a Biomarker for Newly Diagnosed Type 2 Diabetes Mellitus and Associated with Hypoglycemic Effect of Sitagliptin

Peiye Sun,* Yuxi Xiao,* Yuan Dong, Yixiang Feng, Hongting Zheng, Xiaoyu Liao Department of Endocrinology, Translational Research of Diabetes Key Laboratory of Chongqing Education Commission of China, the second Affiliated Hospital of Army Medical University, Chongqing, People’s Repub...

Full description

Saved in:
Bibliographic Details
Main Authors: Sun P, Xiao Y, Dong Y, Feng Y, Zheng H, Liao X
Format: Article
Language:English
Published: Dove Medical Press 2025-03-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
il-22
type 2 diabetes
sitagliptin
intestinal inflammation
Online Access:https://www.dovepress.com/circulating-interleukin-22-is-a-biomarker-for-newly-diagnosed-type-2-d-peer-reviewed-fulltext-article-DMSO
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items